Coexistence of BCR-ABL1 Translocation and JAK2 V617F Mutation in a Patient with Chronic Myeloid Leukemia Under Long-term Treatment with Imatinib and Nilotinib: A Case Report

Coexistence of BCR-ABL1 Translocation and JAK2 V617F Mutation in a Patient with Chronic Myeloid Leukemia Under Long-term Treatment with Imatinib and Nilotinib: A Case Report

This report describes an 89-year-old woman diagnosed with Philadelphia positive Chronic Myeloid Leukemia in 2007 who was initially treated with 200 mg/day imatinib. The patient demonstrated complete molecular response (CMR) in two tests in 2015 and 2018. During treatment between 2007 and 2019, despi...

Full description

Bibliographic Details
Main Authors: Fatemeh Ranjbarnejad, Mozafar Aznab, Kamran Mansouri, Alireza Farrokhi, Tayebeh Ranjbarnejad, Davood Rezazadeh
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2022-01-01
Series:Journal of Mazandaran University of Medical Sciences
Subjects:
imatinib
chronic myeloid leukemia
nilotinib
bcr-abl1
jak2 v617f
Online Access:http://jmums.mazums.ac.ir/article-1-16807-en.html

Internet

http://jmums.mazums.ac.ir/article-1-16807-en.html

Similar Items